Gary C. Evans, Director at NOVAVAX INC (NVAX), sold 46,701 shares at $5.72 ($267K) on 2014-12-16, disclosed to the SEC on 2014-12-18.
Open-market sale of $267k NVAX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| UAMY | BUY | 2024-12-11 | $290K | — | Filing → |
| UAMY | BUY | 2023-01-20 | $10K | — | Filing → |
| UAMY | BUY | 2023-01-17 | $14K | — | Filing → |